"Modern bio-pharmaceuticals are needed in ever-increasing amounts, and are becoming more and more complex to produce. Transgenic plants offer a eukaryotic expression system that is highly scalable, and which may help to address many of the production problems that will be faced in the future. In the last 20 years, proof of concept for a number of plant-derived pharmaceuticals has been obtained and several candidate products are now poised to enter human clinical trials" - Professor Julian Ma - Meetings Chair